CAMDEN, N.J. — A Chattanooga, Tennessee, father is suing the manufacturers of NuvaRing, citing alleged failure to warn of the harmful effects of the contraceptive.
Gregory Ray Adams, as administrator of the estate of Ashley Rae Adams, deceased, filed a complaint Sept. 11 in the U.S. District Court for the District of New Jersey against Organon USA Inc., N.V. Organon, Schering Corp., Merck & Co. Inc. and Merck Sharp & Dohme, alleging they failed to properly disclose the known safety hazards with NuvaRing.
This is a potential tag-along action that should be transferred to the U.S. District Court for the Eastern District of Missouri to be included in a NuvaRing products liability case, according to court documents.
According to the complaint, the plaintiff alleges that on Aug. 20, 2016, his daughter lost consciousness while in the shower while using the NuvaRing contraceptive. She was taken to the hospital but was pronounced dead due to bilateral pulmonary emboli.
The plaintiff alleges the defendants failed to warn prescribing physicians and the public that the NuvaRing was associated with increased risk of cardiovascular thromboembolic complications compared with birth-control pills and failed to provide the Food and Drug Administration with the proper and complete information about the safety of the NuvaRing.
The plaintiff requests a trial by jury and seeks judgment for damages in excess of $75,000, plus attorneys' fees, expenses, costs of action, and such further relief as the Court deems necessary, just and proper. He is represented by David B. Krangle and Andres F. Alonso of Alonso Krangle LLP in Melville, New York.
U.S. District Court for the District of New Jersey case number 4:17-cv-02346-RWS